A report commissioned by the College of Family Physicians of Canada to examine the relationship between doctors and the pharmaceutical industry is being criticized for recommending the status quo.

The document prepared by an internal task force was completed in 2013 and only released this month after a number of doctors challenged the college board to make it public.

In one of its key findings, the report notes the interests of the pharmaceutical industry are "not always aligned with the best interests of the college, its members, or members' patients."

"There have been instances in which marketing messages have been portrayed as education and health care and pharmaceutical industries have attempted in this way to influence physicians' behaviour or practices," it says.

"Evidence suggests that there could also be significant influence on the behaviour of individuals who may be offered gifts or other forms of support, even when the recipients perceive neither obligation nor influence."

The report makes 20 recommendations dealing with issues such as conflict of interest, financial relationships, marketing and other relationships with the pharmaceutical and health care industries.

But they don't prevent a doctor with ties to the pharmaceutical industry from serving in leadership positions, sponsoring certain events, or even from contributing to an "unrestricted" education fund.

'Pretty embarrassing' says drug researcher

Alan Cassels, a drug policy researcher at the University of Victoria, is critical of the college for sitting on the report as long as it did.


University of Victoria drug policy researcher Alan Cassels says he believes the report was held back because it is "basically recommending the status quo between physician education and the pharmaceutical industry.” (Alan Cassels)

He suspects the college held it back because it's "pretty embarrassing."

"They're basically recommending the status quo between physician education and the pharmaceutical industry," he said during an interview with CBC's On The Coast.

"I think they probably produced this report because they would be responding to complaints from their own members. … About 50 per cent of the continuing education that our doctors get is funded by, partnered with, or otherwise led by people who have ties to the pharmaceutical industry."

Cassels says the relationships between the pharmaceutical industry and doctors plays out in "food, flattery and friendship," which pays off for them in face-time with doctors to push their products.

Cassels says there is a correlation between interactions with pharmaceutical reps and how often they prescribe their drugs. 

College says industry money a necessity

Dr. Jamie Meuser, the college's executive director of continuing professional development concedes drug company influence is an issue the college needs "to pay close attention to," but that it's also important for there to be "a wide array of learning opportunities available to our members."

Dr. Jamie Meuser

Dr. Jamie Meuser says the relationship between doctors and the pharmaceutical industry is “something we have to pay close attention to.” (Choosing Wisely Canada/YouTube)

"Currently, some of those learning opportunities are developed with assistance from the health care and pharmaceutical industry. There's no doubt, and those are, along with all other programs that come to us for accreditation ... those are what we apply our standards for quality to," he said.

Meuser says the reason the college doesn't stop taking pharmaceutical money is because without it there would be a "tremendous" gap in funding the continuing education of physicians.

Meuser says the report was only held back because the college considered it a "working document"  more suited to internal discussion.

To hear the interview with Alan Cassels, click the audio labelled: Alan Cassels on doctor-pharmaceutical industry relationship.

To hear the interview with Dr. Jamie Meuser, click the audio labelled: College of Family Physicians of Canada on doctor-pharmaceutical industry relationship.